(Q42780491)

7 November 2017

CYP2C9 polymorphism and warfarin dose requirements (English)

1 reference

7 November 2017

1 reference

1

1 reference

7 November 2017

Guruprasad P Aithal

3

0 references

author name string

Christopher P Day

series ordinal

2

1 reference

PMCID

1874262

7 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

British Journal of Clinical Pharmacology

7 November 2017

1 reference

7 November 2017

53

1 reference

7 November 2017

4

1 reference

7 November 2017

408-409

1 reference

Clinical relevance of genetic polymorphisms in the human CYP2C subfamily

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874262

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874262

The R144C change in the CYP2C9*2 allele alters interaction of the cytochrome P450 with NADPH:cytochrome P450 oxidoreductase

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874262

Genetic analysis of the human cytochrome P450 CYP2C9 locus.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874262

Influence of cytochrome P-450 CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874262

Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese

16 August 2018

1 reference

12 December 2020

Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe

1 reference

12 December 2020

Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9

1 reference

12 December 2020

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population.

1 reference

12 December 2020

Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01572_6.X

Identifiers

DOI

1 reference

7 November 2017

1 reference

7 November 2017

1 reference

PMCID

1874262